GOLPH3 and cancer: Given that MiDAS is elevated in cells challenged with RS and is particularly prevalent in aneuploid cancer cells with oncogene activation30, inhibition of the polymerases playing a specific role in MiDAS might provide an opportunity for therapeutic intervention.